Toxic Shock Syndrome Toxin-1-Mediated Toxicity Inhibited by Neutralizing Antibodies Late in the Course of Continual in Vivo and in Vitro Exposure

Toxic shock syndrome (TSS) results from the host’s overwhelming inflammatory response and cytokine storm mainly due to superantigens (SAgs). There is no effective specific therapy. Application of immunoglobulins has been shown to improve the outcome of the disease and to neutralize SAgs both in vivo...

Descripción completa

Detalles Bibliográficos
Autores principales: Stich, Norbert, Model, Nina, Samstag, Aysen, Gruener, Corina S., Wolf, Hermann M., Eibl, Martha M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073126/
https://www.ncbi.nlm.nih.gov/pubmed/24887085
http://dx.doi.org/10.3390/toxins6061724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073126/
https://www.ncbi.nlm.nih.gov/pubmed/24887085
http://dx.doi.org/10.3390/toxins6061724

Ejemplares similares